A hospital-based matched case–control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection

Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes

(2010) May Nguyen et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Dissemination of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil

(2009) M. Pavez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Diversity of  -Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in Brazil

(2009) R. C. Picao et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Spread ofKlebsiella pneumoniaeCarbapenemases: A Tale of Strains, Plasmids, and Transposons

(2009) L. Silvia Munoz‐Price et al.   CLINICAL INFECTIOUS DISEASES

An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes

(2009) Maria Souli et al.   CLINICAL INFECTIOUS DISEASES

Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns

(2009) Khetam Hussein et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae

(2009) Leanne B. Gasink et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results

(2009) C. G. Carvalhaes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

(2009) Patrice Nordmann et al.   LANCET INFECTIOUS DISEASES

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

First Report of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil

(2008) J. Monteiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes

(2008) D. Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of extended-spectrum β-lactamases in South America

(2008) M.V. Villegas et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and clonality of extended-spectrum β-lactamases in Asia

(2008) P.M. Hawkey   CLINICAL MICROBIOLOGY AND INFECTION

Extended-spectrum β-lactamases in North America, 1987–2006

(2008) K. Bush   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

(2008) Alicia I. Hidron et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Carbapenem-hydrolysing  -lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil

(2008) G. Peirano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES